LI-RADS v2018 category and imaging features: inter-modality agreement between contrast-enhanced CT, gadoxetate disodium-enhanced MRI, and extracellular contrast-enhanced MRI

被引:0
|
作者
Agnello, Francesco [1 ]
Cannella, Roberto [1 ]
Brancatelli, Giuseppe [1 ]
Galia, Massimo [1 ]
机构
[1] Univ Palermo, Dept Radiol, Policlin Paolo Giaccone, Via Vespro 127, I-90127 Palermo, Italy
来源
RADIOLOGIA MEDICA | 2024年 / 129卷 / 11期
关键词
LI-RADS; CT; MRI; Liver; Contrast media; GD-EOB-DTPA; FOCAL LIVER-LESIONS; SMALL HEPATOCELLULAR-CARCINOMA; COMPUTED-TOMOGRAPHY; DELAYED PHASE; DIAGNOSTIC PERFORMANCE; SIGNAL-INTENSITY; HEPATIC NODULES; CIRRHOTIC LIVER; ACID;
D O I
10.1007/s11547-024-01879-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PurposeTo perform an intra-individual comparison of LI-RADS category and imaging features in patients at high risk of hepatocellular carcinoma (HCC) on contrast-enhanced CT, gadoxetate disodium-enhanced MRI (EOB-MRI), and extracellular agent-enhanced MRI (ECA-MRI) and to analyze the diagnostic performance of each imaging modality.MethodThis retrospective study included cirrhotic patients with at least one LR-3, LR-4, LR-5, LR-M or LR-TIV observation imaged with at least two imaging modalities among CT, EOB-MRI, or ECA-MRI. Two radiologists evaluated the observations using the LI-RADS v2018 diagnostic algorithm. Reference standard included pathologic confirmation and imaging criteria according to LI-RADS v2018. Imaging features were compared between different exams using the McNemar test. Inter-modality agreement was calculated by using the weighted Cohen's kappa (k) test.ResultsA total of 144 observations (mean size 34.0 +/- 32.4 mm) in 96 patients were included. There were no significant differences in the detection of major and ancillary imaging features between the three imaging modalities. When considering all the observations, inter-modality agreement for category assignment was substantial between CT and EOB-MRI (k 0.60; 95%CI 0.44, 0.75), moderate between CT and ECA-MRI (k 0.46; 95%CI 0.22, 0.69) and substantial between EOB-MRI and ECA-MRI (k 0.72; 95%CI 0.59, 0.85). In observations smaller than 20 mm, inter-modality agreement was fair between CT and EOB-MRI (k 0.26; 95%CI 0.05, 0.47), moderate between CT and ECA-MRI (k 0.42; 95%CI -0.02, 0.88), and substantial between EOB-MRI and ECA-MRI (k 0.65; 95%CI 0.47, 0.82). ECA-MRI demonstrated the highest sensitivity (70%) and specificity (100%) when considering LR-5 as predictor of HCC.ConclusionsInter-modality agreement between CT, ECA-MRI, and EOB-MRI decreases in observations smaller than 20 mm. ECA-MRI has the provided higher sensitivity for the diagnosis of HCC.
引用
收藏
页码:1575 / 1586
页数:12
相关论文
共 50 条
  • [31] LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium enhanced MRI
    Lee, Sang Min
    Lee, Jeong Min
    Ahn, Su Joa
    Kang, Hyo-Jin
    Yang, Hyun Kyung
    Yoon, Jeong Hee
    RADIOLOGY, 2019, 292 (03) : 655 - 663
  • [32] Impact of Reference Standard on CT, MRI, and Contrast-enhanced US LI-RADS Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis
    van der Pol, Christian B.
    McInnes, Matthew D. F.
    Salameh, Jean-Paul
    Chernyak, Victoria
    Tang, An
    Bashir, Mustafa R.
    RADIOLOGY, 2022, 303 (03) : 544 - 545
  • [33] Can Contrast-enhanced MRI using Gadoxetate Disodium (Eovist) Replace Triphasic CT to Derive Future Liver Remnant?
    Le, V. H.
    Trocha, S. D.
    Jones, W. B.
    Devane, M. A.
    McKinley, B. P.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S102 - S102
  • [34] Can contrast-enhanced MRI using gadoxetate disodium (EOVIST) replace triphasic CT to derive future liver remnant?
    Le, Viet H.
    Trocha, Steven D.
    Jones, Wesley B.
    Devane, Michael A.
    McKinley, Brian
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [35] Bipolar radiofrequency ablation for liver tumors: comparison of contrast-enhanced ultrasound with contrast-enhanced MRI/CT in the posttreatment imaging evaluation
    Bo, Xiao-Wan
    Xu, Hui-Xiong
    Sun, Li-Ping
    Zheng, Shu-Guang
    Guo, Le-Hang
    Lu, Feng
    Wu, Jian
    Xu, Xiao-Hong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (09): : 6108 - 6116
  • [36] Dynamic contrast-enhanced MRI perfusion quantification in hepatocellular carcinoma: comparison of gadoxetate disodium and gadobenate dimeglumine
    Stocker, Daniel
    Hectors, Stefanie
    Bane, Octavia
    Vietti-Violi, Naik
    Said, Daniela
    Kennedy, Paul
    Cuevas, Jordan
    Cunha, Guilherme M.
    Sirlin, Claude B.
    Fowler, Kathryn J.
    Lewis, Sara
    Taouli, Bachir
    EUROPEAN RADIOLOGY, 2021, 31 (12) : 9306 - 9315
  • [37] Hepatic schwannoma:Imaging findings on CT,MRI and contrast-enhanced ultrasonography
    Yu Ota
    Kazunobu Aso
    Kenji Watanabe
    Takahiro Einama
    Koji Imai
    Hidenori Karasaki
    Ryuji Sudo
    Yosui Tamaki
    Mituyoshi Okada
    Yosihiko Tokusashi
    Toru Kono
    Naoyuki Miyokawa
    Masakazu Haneda
    Masahiko Taniguchi
    Hiroyuki Furukawa
    World Journal of Gastroenterology, 2012, (35) : 4967 - 4972
  • [38] Extended application of subtraction arterial phase imaging in LI-RADS version 2018: a strategy to improve the diagnostic performance for hepatocellular carcinoma on gadoxetate disodium-enhanced MRI
    Kim, Seung-seob
    Lee, Sunyoung
    Bae, Heejin
    Chung, Yong Eun
    Choi, Jin-Young
    Park, Mi-Suk
    Kim, Myeong-Jin
    EUROPEAN RADIOLOGY, 2021, 31 (03) : 1620 - 1629
  • [39] Hepatic schwannoma: Imaging findings on CT, MRI and contrast-enhanced ultrasonography
    Ota, Yu
    Aso, Kazunobu
    Watanabe, Kenji
    Einama, Takahiro
    Imai, Koji
    Karasaki, Hidenori
    Sudo, Ryuji
    Tamaki, Yosui
    Okada, Mituyoshi
    Tokusashi, Yosihiko
    Kono, Toru
    Miyokawa, Naoyuki
    Haneda, Masakazu
    Taniguchi, Masahiko
    Furukawa, Hiroyuki
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (35) : 4967 - 4972
  • [40] Fusion Imaging of Contrast-enhanced Ultrasound With CT or MRI for Kidney Lesions
    Auer, Thomas
    Heidegger, Isabel
    De Zordo, Tobias
    Junker, Daniel
    Jaschke, Werner
    Steinkohl, Fabian
    Aigner, Friedrich
    IN VIVO, 2019, 33 (01): : 203 - 208